Enabling a CDMO to Modernize Validation and Save 1.5 FTE Annually

Despite that ambition, the company's validation processes hadn't kept up. Most systems still relied on paper or paper-on-glass approaches, and a growing backlog of more than five releases made it difficult to keep pace with operational demands. With no common validation platform across sites, there was limited transparency and little ability to control or coordinate validation activity at an organizational level.

The company recognized that its existing approach put it at a disadvantage with regulators and with the customers it served. Modernizing wasn't optional; it was a competitive and compliance imperative.

Sware deployed the Res_Q Validation Management Platform to give the company a consolidated, modern foundation for all validation activity. Historical validation packages were migrated into the unified system, eliminating the scattered, siloed records that had made audits and change management difficult.

From there, Res_Q established standardized validation processes across sites, streamlining day-to-day operations and creating a single source of truth for all validation documentation. The result was full traceability at every point in the validation chain, with audit-readiness built in rather than bolted on.

The impact was measurable. The company is projected to save 1.5 FTE annually on ERP validation efforts alone, and is now FDA audit-ready with modernized, data-first validation that can be traced end to end. The partnership with Sware continues, with ongoing collaboration to refine existing processes and onboard new Res_Q capabilities as the company sees further into what compliant, future-proofed validation can look like.